Viewing Study NCT00968305

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:29 AM
Ignite Modification Date: 2026-02-05 @ 11:29 PM
Study NCT ID: NCT00968305
Status: COMPLETED
Last Update Posted: 2009-08-28
First Post: 2009-08-19
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Interleukin (IL)-13 as a Marker in Pediatrics Asthma
Sponsor: Rush University Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Asthma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None African American children with stable asthma View
None Asthma severity View
None Interleukin 13 from PHA stimulated PBMC View
None Lung function (FEV1%) View
None Total serum IgE View
None Pediatrics View